BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8084449)

  • 1. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.
    Merkel F; Pullig O; Marx M; Netzer KO; Weber M
    Nephrol Dial Transplant; 1994; 9(4):372-6. PubMed ID: 8084449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-GBM disease: predictive value of clinical, histological and serological data.
    Herody M; Bobrie G; Gouarin C; Grünfeld JP; Noel LH
    Clin Nephrol; 1993 Nov; 40(5):249-55. PubMed ID: 8281713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].
    Bouget J; Le Pogamp P; Perrier G; Ramée MP; Rivalan J; Camus C; Thomas R; Chevet D
    Ann Med Interne (Paris); 1990; 141(5):409-15. PubMed ID: 2256583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual presentations of anti-glomerular basement membrane antibody mediated disease are associated with delayed diagnosis and poor outcome.
    Andrews PA; Sheerin NS; Hicks JA; Williams DG; Sacks SH
    Clin Nephrol; 1995 Oct; 44(4):262-5. PubMed ID: 8575127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
    Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
    Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome).
    Holdsworth S; Boyce N; Thomson NM; Atkins RC
    Q J Med; 1985 Apr; 55(216):75-86. PubMed ID: 4011844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-glomerular basement membrane antibody mediated disease: revision of 32 cases and follow-up at one year of the diagnosis].
    Saurina A; Arrizabalaga P; Rodríguez R; Poveda R; Vallés M; Pou M; Mirapeix E
    Nefrologia; 2003; 23(5):415-22. PubMed ID: 14658167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease.
    Cui Z; Zhao MH; Xin G; Wang HY
    Nephron Clin Pract; 2005; 99(2):c49-55. PubMed ID: 15637429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
    Hu W; Liu Z; Ji D; Xie H; Gong D; Li L
    J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome.
    Pasternack A; Törnroth T; Linder E
    Clin Nephrol; 1978 Feb; 9(2):77-85. PubMed ID: 147761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange.
    Hind CR; Bowman C; Winearls CG; Lockwood CM
    Clin Nephrol; 1984 Apr; 21(4):244-6. PubMed ID: 6733989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Goodpasture's syndrome with IgA antibasement membrane antibody].
    Nakano H; Suzuki A; Tojima H; Watanabe A; Mizuguchi K; Shinozaki T; Kamei K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):634-8. PubMed ID: 2214406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-novo anti-GBM-antibody-induced glomerulonephritis in a renal transplant.
    Boyce N; Holdsworth S; Atkins R; Dowling J
    Clin Nephrol; 1985 Mar; 23(3):148-51. PubMed ID: 3886231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and features of dual anti-GBM-positive and ANCA-positive patients.
    DE Zoysa J; Taylor D; Thein H; Yehia M
    Nephrology (Carlton); 2011 Nov; 16(8):725-9. PubMed ID: 21649794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of anti-basement membrane (BM) mediated disease presenting renal and pulmonary symptoms by divergent timing].
    Usutani S; Nosaka H; Shirai M; Akimoto H; Kojima K; Shimomura M; Kakuta S; Nagase M; Sado Y
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):512-6. PubMed ID: 9283218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome.
    Cove-Smith JR; McLeod AA; Blamey RW; Knapp MS; Reeves WG; Wilson CB
    Clin Nephrol; 1978 Mar; 9(3):126-8. PubMed ID: 346273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.